Patent Assignment
Reel/Frame 073516/0522
Release of Security Interest
Recorded: 2025-11-10
Pages: 25
Assignor
WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Executed: 2025-10-17
Assignees
VALNEVA AUSTRIA GMBH
CAMPUS VIENNA BIOCENTER 3, VIENNA, 1030, AUSTRIA
VALNEVA SE
6 RUE ALAIN BOMBARD, SAINT HERBLAIN, 44800, FRANCE
VALNEVA USA, INC.
4550 MONTGOMERY AVE., SUITE 460, BETHESDA, MARYLAND, 20814
Covered Properties
(73)
Methods and Compositions Comprising Polycationic Compounds
Antigenic Composition
Methods and Compositions Involving Immunostimulatory Oligodeoxynucleotides
Vaccine Composition Comprising an Antigen and a Peptide Having Adjuvant Properties
Vaccines
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
Vaccine Composition Comprising An Antigen And A Peptide Having Adjuvant Properties
A Method of Obtaining Chicken Embryonic Stem Cells
A Method of Making an Avian Cell Line
Vaccines Comprising an Immunostimulatory Peptide and an Immunostimulatory Oligodeoxynucleic Acid Molecule
Avian Cell Lines
Application:
13/206,056 →
Publication:
US 2011/0294209
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
Aluminum Compounds for Use in Therapeutics and Vaccines
Methods and Compositions Involving Immunostimulatory Oligodeoxynucleotides
MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO
Generation of Duck Cell Lines
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Methods and Compositions Involving Immunostimulatory Oligodeoxynucleotides
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
Aluminum Compounds for Use in Therapeutics and Vaccines
Method of Making a Virus Using Duck Embryonic Derived Stem Cell Lines
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Aluminum Compounds for Use in Therapeutics and Vaccines
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Aseptic Purification Process for Viruses
Zika Virus Purification
Virus Purification
Duck Embryonic Derived Stem Cell Lines for the Production of Viral Vaccines
Application:
15/785,530 →
Publication:
US 2018/0135026
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Zika Virus Purification
Virus Purification
Zika Virus Vaccine
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Multivalent Ospa Polypeptides and Methods and Uses Relating Thereto
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Virus Purification
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Aluminum Compounds for Use in Therapeutics and Vaccines
Zika Virus Vaccine
Aseptic Purification Process for Viruses
Virus Purification
Zika Virus Purification
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Method for Rescuing and Producing a Virus in Avian Cells
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NP3
CpG-ADJUVANTED SARS-CoV-2 VIRUS VACCINE
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Zika Virus Vaccine
A Subunit Vaccine for Treatment or Prevention of a Respiratory Tract Infection
Chikungunya Vaccine Formulations
Application:
17/632,943 →
Publication:
US 2022/0288185
Single Shot Chikungunya Virus Vaccine
Application:
17/632,946 →
Publication:
US 2022/0313810
Inactivation Process for Viruses
Application:
17/688,960 →
Publication:
US 2022/0298493
Virus Purification
Improvements in Vaccine Formulations for Medical Use
Application:
17/917,010 →
Publication:
US 2023/0398210
Improved Methods of Producing a Lipidated Protein
Application:
17/917,016 →
Publication:
US 2024/0026412
Compositions Comprising Three Ospa Fusion Proteins for Medical Use
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application:
17/932,226 →
Publication:
US 2023/0295245
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Cholera Vaccine Formulation
Application:
18/027,657 →
Publication:
US 2023/0372464
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application:
18/150,971 →
Publication:
US 2023/0322869
Zika Virus Vaccine
Human Metapneumo Virus Vaccine
Application:
18/285,416 →
Publication:
US 2024/0181034
Human Metapneumovirus Combination Vaccine
Application:
18/285,417 →
Publication:
US 2024/0358812
Zika Virus Vaccine
Subunit Vaccine for Treatment or Prevention of a Respiratory Tract Infection
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 9, 2007
From: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
To: INTERCELL AG
Reel/Frame 018876/0637 →
Assignment of Assignor's Interest
Mar 29, 2007
From: BUSCHLE, MICHAEL; HABEL, ANDRE; FRITZ, JORG; PRINZ, KARIN
To: INTERCELL AG
Reel/Frame 019085/0711 →
Assignment of Assignor's Interest
Jan 14, 2009
From: MEHTALI, MAJID; CHAMPION-ARNAUD, PATRICK; LEON, ARNAUD
To: VIVALIS
Reel/Frame 022106/0677 →
Assignment of Assignor's Interest
Apr 21, 2010
From: VALARCHE, ISABELLE; BATARD, LUC; MEHTALI, MAJID
To: VIVALIS
Reel/Frame 024264/0067 →
Assignment of Assignor's Interest
Jun 10, 2011
From: BUSCHLE, MICHAEL; HABEL, ANDRE; FRITZ, JORG; PRINZ, KARIN
To: INTERCELL AG
Reel/Frame 026422/0343 →
Assignment of Assignor's Interest
Jun 12, 2012
From: SCHLEGL, ROBERT; MOHLEN, MICHAEL; WRUSS, JURGEN; WEBER, MICHAEL
To: INTERCELL AG
Reel/Frame 028358/0972 →
Change of Name
May 10, 2013
From: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
To: INTERCELL AG
Reel/Frame 030393/0937 →
Assignment of Assignor's Interest
May 10, 2013
From: SCHMIDT, WALTER; LINGNAU, KAREN; SCHELLACK, CAROLA; EGYED, ALENA
To: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
Reel/Frame 030393/0857 →
Assignment of Assignor's Interest
Jun 4, 2013
From: COMSTEDT, PAR; HANNER, MARKUS; LUNDBERG, URBAN; MEINKE, ANDREAS
To: INTERCELL AG
Reel/Frame 030541/0775 →
Asset Transfer Agreement
Jun 13, 2013
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 030610/0627 →
Change of Name
Sep 25, 2013
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 031283/0473 →
Asset Transfer Agreement
Sep 25, 2013
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 031283/0233 →
Change of Name
Nov 15, 2013
From: VIVALIS SA
To: VALNEVA SE
Reel/Frame 031607/0481 →
Assignment of Assignor's Interest
Nov 15, 2013
From: GUEHENNEUX, FABIENNE; MOREAU, KARINE; ESNAULT, MAGALI; MEHTALI, MAJID
To: VIVALIS SA
Reel/Frame 031607/0429 →
Corrective Assignment to Correct the Change of Name Recordation Previously Recorded on Reel 031607 Frame 0481. Assignor(S) Hereby Confirms the Conveying Party: Vivalis Receiving Party: Valneva.
Dec 12, 2013
From: VIVALIS
To: VALNEVA
Reel/Frame 031804/0451 →
Change of Name
Jan 24, 2014
From: VIVALIS
To: VALNEVA
Reel/Frame 032036/0864 →
Asset Transfer Agreement
Feb 21, 2014
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 032308/0509 →
Change of Name
Feb 21, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 032262/0068 →
Change of Name
Mar 21, 2014
From: VIVALIS
To: VALNEVA
Reel/Frame 032497/0739 →
Asset Transfer Agreement
Apr 10, 2014
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 032651/0786 →
Change of Name
Apr 10, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 032642/0164 →
Asset Transfer Agreement
May 14, 2014
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 032893/0712 →
Change of Name
May 14, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 032887/0896 →
Assignment of Assignor's Interest
Sep 9, 2014
From: GUEHENNEUX, FABIENNE
To: VALNEVA
Reel/Frame 033697/0396 →
Change of Name
Sep 19, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 033776/0800 →